Plasminogen activator inhibitors in human tears. 1991

J Tözsér, and A Berta
Department of Biochemistry, Medical University of Debrecen, Hungary.

Plasminogen activator inhibitor activity was demonstrated in tears of patients suffering from various corneal and conjunctival diseases. Active plasminogen activator inhibitor was also detected by reverse fibrin zymography in tears of a patient suffering from Sjögren's syndrome and in those who underwent eye surgery. Immunoblotting revealed that both type 1 and type 2 plasminogen activator inhibitors may be present in human tears when the epithelial cells of the cornea and conjunctiva are affected and/or the permeability of the conjunctival blood vessels is increased. The molecular weight of inhibitors suggested the simultaneous presence of both free and activator-complexed inhibitors. However, no plasminogen activator inhibitor was detectable in normal human tears, suggesting that the presence of plasminogen activator inhibitors in tears may be associated with the pathological events at the ocular surface.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D003229 Conjunctival Diseases Diseases involving the CONJUNCTIVA. Conjunctival Disease,Disease, Conjunctival,Diseases, Conjunctival
D003316 Corneal Diseases Diseases of the cornea. Corneal Disease,Disease, Corneal,Diseases, Corneal
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005136 Eye Proteins PROTEINS derived from TISSUES of the EYE. Proteins, Eye
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013666 Tears The fluid secreted by the lacrimal glands. This fluid moistens the CONJUNCTIVA and CORNEA. Meibomian Lipids,Meibum,Lipid, Meibomian,Meibomian Lipid,Tear
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D015849 Plasminogen Inactivators Important modulators of the activity of plasminogen activators. The inhibitors belong to the serpin family of proteins and inhibit both the tissue-type and urokinase-type plasminogen activators. Plasminogen Activator Inhibitor,Plasminogen Activator Inhibitors,Endothelial Plasminogen Activator Inhibitors,Placental Plasminogen Activator Inhibitors,Plasminogen Activator Inhibitors, Endothelial,Plasminogen Activator Inhibitors, Placental,Activator Inhibitor, Plasminogen,Inactivators, Plasminogen,Inhibitor, Plasminogen Activator,Inhibitors, Plasminogen Activator

Related Publications

J Tözsér, and A Berta
January 1992, Eye (London, England),
J Tözsér, and A Berta
September 2004, Frontiers in bioscience : a journal and virtual library,
J Tözsér, and A Berta
June 2008, Journal of cataract and refractive surgery,
J Tözsér, and A Berta
February 1988, Experimental eye research,
J Tözsér, and A Berta
February 1987, Blood,
J Tözsér, and A Berta
January 1991, Postepy biochemii,
J Tözsér, and A Berta
April 1991, Trends in cardiovascular medicine,
J Tözsér, and A Berta
January 2017, PloS one,
Copied contents to your clipboard!